Previously, most contracting states of the European Patent Convention (EPC) require the filing of a translation of the specification in order for a granted European patent to come into force in that state. This validation process and, in particular, the requirement...
Background Following C-34/10, any non-fertilised human ovum for which division and further development are stimulated by parthenogenesis was to be considered a “human embryo”. Such a non-fertilised and stimulated human ovum is called a parthenote. The CJEU’s ruling in...
Until now, exceptions to patent infringement in the UK were limited, so manufacturers preparing for regulatory approval risked an infringement action. Legislation will come into force in the UK on 1 October 2014 that finally provides broad exemption from patent...
The scope for patenting stem cell-based inventions in Europe was dealt a blow by the judgement of the CJEU in Brüstle vs Greenpeace (C 34/10)1. The practical result of this judgement was that the earliest date from which the EPO would acknowledge that morally...
Biopiracy is the evil sibling of bioprospecting. Bioprospecting is the search for existing genetic resources and biological knowledge that can be applied more widely and in novel applications. This is an area of particular interest to the pharmaceutical industry...
Therefore, applicants may wish to consider filing any available complete applications and national phase entry applications in New Zealand prior to 13 September 2014 in order to not only avoid the more stringent patentability requirements of the New Act but also to...
Recent Comments